Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel plus aspirin vs aspirin alone for acute treatment of TIA or minor stroke
2005-005763-28Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clopidogrel in transient ischaemic attack (TIA) and ischemic stroke (2 arms), sponsored by Sanofi. Primary endpoint: Primary efficacy endpoint. Started Jun 2006; status: terminated.
02
Drugs
clopidogrel
03
Conditions
transient ischaemic attack (TIA)ischemic stroke
Beyond the preview
Go deeper on 2005-005763-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005763-28.